Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2025-01-10 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
(Revised) Next Day Disclosure Return (Date of repurchase: 18 December 2024)
Transaction in Own Shares Classification · 88% confidence The document is a Hong Kong Stock Exchange “Next Day Disclosure Return (FF305)” detailing changes in issued shares, treasury shares, and on-market repurchases of shares by Pharmaron Beijing Co., Ltd. It includes specific sections on repurchase dates, volumes, prices, and confirmation under Main Board/GEM Rules. This is neither an annual report, earnings release, nor a governance or voting announcement, but rather a disclosure of the company buying back its own shares. According to the filing definitions, this fits “Transaction in Own Shares” (Code: POS).
2025-01-10 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-01-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings Classification · 85% confidence The document is the FF301 "Monthly Return for Equity Issuer and Hong Kong Depositary Receipts" submitted to HKEX under Chapter 19B of the Listing Rules, detailing share capital movements, treasury shares, repurchases and cancellations for the month ended 31 December 2024. It is not an earnings release, proxy statement, dividend notice, or call transcript; it is a routine regulatory return under HKEX rules. It does not announce a discrete capital change (SHA) event beyond the monthly summary, nor is it a standalone annual or interim report. Therefore, it best fits into the general Regulatory Filings category (RNS).
2025-01-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-01-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a regulatory disclosure form (FF305 Next Day Disclosure Return) under Hong Kong Stock Exchange listing rules detailing changes in issued shares, treasury shares, and a share repurchase report (on-market repurchase of 542,000 shares). This is not an annual or interim financial report, earnings release, management change, or voting results, but a transaction in own shares. Hence it should be classified as POS (Transaction in Own Shares).
2025-01-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Stock Exchange "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares and treasury shares, specifically share repurchases on-market. It is not a broad annual or interim report, nor a proxy or management presentation. It is a regulatory disclosure of transactions in the company’s own shares (repurchases/sales), matching our "Transaction in Own Shares" category (POS).
2024-12-31 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.